Purchase Order 75F40123P00417
Award Date 9/18/23
Potential Completion Date 10/14/24
Potential Value $138K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Menlo Park, CA 94025, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Food and Drug Administration awarded a purchase order to Chapter Diagnostics Inc. for $130,000 on July 11, 2023, to design and develop next-generation targeted sequencing reagents, baits, and software for the detection and typing of Campylobacter spp. from food and environmental matrices. The order is set-aside for total small business. Work is performed in Menlo Park, California. The procurement originated from a special notice posted June 8, 2023, with a June 23 response deadline. Ultimate...
- The U.S. Food and Drug Administration awarded a $48,715.20 firm fixed-price purchase order to Pacific Biosciences of California, Inc. for Revio reagent kits (part number 102-817-900) with an ultimate completion date of September 9, 2024. This award represents a direct procurement of consumable supplies critical to next-generation DNA sequencing operations. Pacific Biosciences is a leading biotechnology manufacturer headquartered in Menlo Park, California, specializing in advanced sequencing...
- The Food and Drug Administration awarded a $22.9K firm fixed-price purchase order to Pacific Biosciences of California, Inc., a Menlo Park-based biotechnology manufacturer specializing in advanced DNA and RNA sequencing technologies. The award, designated as a total small business set-aside, was executed on July 27, 2021, for SMRT cell 8M trays and Sequel II sequencing kits—consumable products essential for next-generation sequencing operations. The procurement was completed ahead of the October...
- This is a delivery order awarded to Pacific Biosciences of California, Inc., a manufacturer of DNA/RNA sequencing systems and associated consumables, by the Department of Health and Human Services' Food and Drug Administration. The $69,567.00 firm-fixed-price order is for the provision of sequencing reagents, kits, and consumables to support the agency's genomic research initiatives. Pacific Biosciences has extensive experience providing specialized sequencing equipment and supplies to various...
- The Department of Health and Human Services Food and Drug Administration awarded a $43,337.06 firm fixed price delivery order to Pacific Biosciences of California, Inc. under the agency's indefinite-delivery/indefinite-quantity contract 75F40121D00007. The delivery order is for the purchase of specific supplies and reagents for use with Pacific Biosciences' PacBio Sequel IIE long-read DNA/RNA sequencer to support the FDA's regulatory science programs. Performance will occur in Laurel, Maryland...
- The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a $110,000 delivery order contract to Illumina, Inc. for Illumina Reagent Chemistry Kits. The firm fixed price contract runs from April 5, 2023 through September 25, 2023 and will be performed in Silver Spring, Maryland. The HHS FDA utilizes next generation sequencing technologies and associated reagents in its regulatory and research activities. No subcontractors or set aside designations were identified....
- This federal contract award, valued at $104,968.99, was issued by the Food and Drug Administration (FDA) to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The contract is for the delivery of Illumina reagent (chemistry) kits, with an ultimate completion date of September 14, 2022. The contract is a firm fixed-price Delivery Order with no set-aside designation. Illumina has a history of providing sequencing systems, reagents, and related services to various federal...
- The Food and Drug Administration awarded a $47,897.16 delivery order to Pacific Biosciences of California, Inc. on March 30, 2026, for supplies and reagents supporting the PacBio Sequel IIe long-read DNA/RNA sequencer. This delivery order was issued under the FDA's existing Indefinite Delivery Indefinite Quantity (IDIQ) contract 75F40121D00007 with Pacific Biosciences, valued at $1 million and originally extending through March 2025. The work will be performed in Laurel, Maryland, with an...
- The Department of Health and Human Services' Food and Drug Administration awarded a $749,396.58 firm fixed price purchase order to Pacific Biosciences of California, Inc. to deliver a Versatile Sequencing II System. The sequencing system must be capable of producing long reads between 8,000 to over 20,000 bases, running a minimum of eight multiplexed samples simultaneously, and accommodating a cell confinement structure with 100,000 to 150,000 zero-mode waveguide holes, as specified in the...
- <p>The Food and Drug Administration issued a $33,175 delivery order to Pacific Biosciences of California, Inc. on August 29, 2023, for sequencing reagents and supplies including AmpureXP, HiFi Express template prep kit, Sequel binding kit, Sequel sequencing kit, and SMRT cell trays.</p> <p>Place of performance is Silver Spring, MD. The order is firm fixed price with an ultimate completion date of March 30, 2024. No set-aside was used.</p>